INDICATIONS

Relieves occasional constipation (irregularity).

Senokot Laxatives provide a virtually colon-specific action which is gentle, effective and predictable, generally producing bowel movement in 6 to 12 hours.

SENOKOT Tablets contain a natural vegetable laxative ingredient standardized for uniform action.

SENOKOT has been found to be effective even in many previously intractable cases of functional constipation. SENOKOT preparations may aid in rehabilitation of the constipated patient by facilitating regular elimination. SENOKOT preparations enjoy patient acceptance. Numerous and extensive clinical studies show their high degree of effectiveness in several types of functional constipation: geriatric and postpartum, drug-induced, pediatric, as well as in functional constipation concurrent with heart disease or anorectal surgery.

SENOKOT-S Tablets are designed to relieve both aspects of functional constipation--bowel inertia and hard, dry stools. They provide a stimulant combined with a classic stool softener, standardized senna concentrate gently stimulates the colon while docusate sodium softens the stool for smoother and easier evacuation. This coordinated dual action of the two ingredients results in colon-specific, predictable laxative effect, generally producing bowel movement in 6 to 12 hours. Flexibility of dosage permits adjustment to individual requirements. SENOKOT-S Tablets are suitable for relief of postsurgical and postpartum constipation, and effectively relieve drug-induced constipation.

DESCRIPTION

SENOKOT Tablets:   Each tablet contains 8.6 mg sennosides.

Active Ingredient: Standardized Senna Concentrate.

Inactive Ingredients: Croscarmellose sodium, Dicalcium phosphate, Hypromellose, Magnesium stearate, Microcrystalline cellulose, Mineral oil.

SENOKOT-S Tablets:   Each tablet contains 8.6 mg sennosides and 50 mg of docusate sodium. Active Ingredients: Docusate Sodium and Standardized Senna Concentrate.

Inactive Ingredients:    Carnauba wax, Colloidal silicon dioxide, Croscarmellose sodium, Dicalcium phosphate, D&C Yellow #10, FD&C Yellow #6, Hypromellose, Magnesium stearate, Microcrystalline cellulose, PEG 8000, Sodium benzoate, Stearic acid, Titanium dioxide.

RECOMMENDED DOSAGE

(or as directed by a doctor): Take preferably at bedtime. Dosing for Senokot Tablets is available for children as young as 2 years. For children under 2 years of age, consult a physician.

SENOKOT ® Tablets and SENOKOT-S ® Tablets:

Recommended Dosage (or as directed by a doctor):

Take preferably at bedtime.

AGE
STARTING
Adults and children
12 years of age
or older
2 tablets
once a day
4 tablets
twice a day
6 to under
12 years
1 tablet
once a day
2 tablets
twice a day
2 to under
6 years
1 / 2 tablet
once a day
1 tablet
twice a day
Under 2 years
Ask a doctor

WARNINGS

Do not use laxative products for longer than 1 week unless directed by a doctor.

Ask a doctor before use if you have stomach pain, nausea, vomiting, or noticed a sudden change in bowel habits that continues over a period of 2 weeks.

Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Other information

Senokot

each tablet contains: calcium 25mg

Store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F)

Senokot-S

each tablet contains: calcium 20mg, sodium 4mg VERY LOW SODIUM

Store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F)

HOW SUPPLIED

Senokot Tablets:   Blister packs of 20. Bottles of 50 and 100. Unit Strip Packs in boxes of 100 tablets: each tablet individually sealed.

Senokot-S Tablets: Blister packs of 10. Bottles of 30 and 60, and Unit Strip Boxes of 100 tablets.

Copyright 2004, 2005, Purdue Products L.P., Stamford, CT
06901-3431

PRODUCT PHOTO(S):

NOTE: These photos can be used only for identification by shape, color, and imprint. They do not depict actual or relative size.

The product samples shown here have been supplied by the manufacturer and reproduced in full color by PDR as a quick-reference identification aid. While every effort has been made to assure accurate reproduction, please remember that any visual identification should be considered preliminary. In cases of poisoning or suspected overdosage, the drug's identity should be verified by chemical analysis.

images/pills/n05515d1.jpg
images/pills/n05515d2.jpg
images/pills/p06330e4.jpg
images/pills/p06330e5.jpg



Copyright© 2006 Thomson PDR